Indexed metadata
Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial
Viola Klück, Tim L Th A Jansen, Matthijs Janssen, Antoaneta Comarniceanu, Monique Efdé, Isak W Tengesdal, Kiki Schraa, Maartje C P Cleophas, Curtis L Scribner, Damaris B Skouras, Carlo Marchetti, Charles A Dinarello, Leo A B Joosten
Source record
Source: Crossref
Published: May 1, 2020
DOI: 10.1016/s2665-9913(20)30065-5
Open original source ↗Evidence graph
No public relationships recorded yet.
Integrity note: This page is a factual metadata record created by deterministic ingestion. It is not a claim that the work moves a mathematical frontier or has been independently verified.